Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Polypid Ltd (PYPD)

Polypid Ltd (PYPD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Polypid Ltd 18 HASIVIM STREET PETACH TIKVA L3 495376 ISR

www.polypid.com Employees: 61 P: 972-74-719-5700

Sector:

Medical

Description:

PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.

Key Statistics

Overview:

Market Capitalization, $K 71,854
Enterprise Value, $K 63,464
Shares Outstanding, K 15,897
Float, K 11,970
% Float 75.30%
Short Interest, K 19
Short Float 0.12%
Days to Cover 1.00
Short Volume Ratio 0.47
% of Insider Shareholders 24.70%
% of Institutional Shareholders 26.47%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -29,020 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,450 K
EBIT, $ -32,660 K
EBITDA, $ -31,040 K

Growth:

1-Year Return 55.86%
3-Year Return -80.16%
5-Year Return -99.01%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/12/25
Next Earnings Date 02/11/26 [BMO]
Earnings Per Share ttm -2.98
EPS Growth vs. Prev Qtr 52.56%
EPS Growth vs. Prev Year 69.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 09/21/23

PYPD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -313.65%
Return-on-Assets % -128.32%
Profit Margin % 0.00%
Debt/Equity 0.16
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.50
Book Value/Share 0.97
Interest Coverage -4.55
60-Month Beta 1.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar